Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perhexiline therapy in patients with hypertrophic cardiomyopathy
2005-000755-15Phase 3Unknown
- Sponsor
- University Hospitals Birmingham
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of piroxicam-beta-cyclodextrin in hypertrophic cardiomyopathy (HCM), sponsored by University Hospitals Birmingham. Primary endpoint: Peak VO2. Status: unknown.
02
Drugs
piroxicam-beta-cyclodextrin
03
Conditions
hypertrophic cardiomyopathy (HCM)
Beyond the preview
Go deeper on 2005-000755-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000755-15.